I

iBio
D

IBIO

3.45000
USD
-0.13
(-3.63%)
مغلق
حجم التداول
5,880
الربح لكل سهم
-2
العائد الربحي
-
P/E
3
حجم السوق
34,067,632
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ABEO
    -0.04000
    (-0.69%)
    5.78000 USD
    A
    ACRS
    -0.08000
    (-3.45%)
    2.24000 USD
    A
    ADAP
    -0.01800
    (-3.11%)
    0.56000 USD
    A
    ADC
    1.500
    (2.10%)
    72.830 USD
    ALNY
    ALNY
    -0.480
    (-0.19%)
    250.450 USD
    B
    BCLI
    -0.08000
    (-4.42%)
    1.73000 USD
    A
    ATYR
    -0.11500
    (-2.60%)
    4.31500 USD
    المزيد
الأخبار
المقالات

العنوان: iBio

القطاع: Healthcare
الصناعة: Biotechnology
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.